Targeted Inhibition of the miR-199a/214 Cluster by CRISPR Interference Augments the Tumor Tropism of Human Induced Pluripotent Stem Cell-Derived Neural Stem Cells under Hypoxic Condition.

Targeted Inhibition of the miR-199a/214 Cluster by CRISPR Interference Augments the Tumor Tropism of Human Induced Pluripotent Stem Cell-Derived Neural Stem Cells under Hypoxic Condition.
复制标题

DOI:
10.1155/2016/3598542
复制
发表时间:
2016
影响因子:
4.3
通讯作者:
Zhu D
Zhu D
中科院分区:
医学3区
文献类型:
--
作者:
Luo Y;Xu X;An X;Sun X;Wang S;Zhu D

文献摘要

参考文献

被引文献

相似文献

人类诱导多能干细胞(HiPSC)提供了一种突破性的方法,有助于克服神经干细胞(NSCs)在靶向癌症基因治疗中应用所带来的伦理和致敏挑战。然而,HiPSC来源的神经干细胞(HIPS-NSCs)的趋瘤能力仍有很大的提高空间。在这里,我们试图通过调控内源性miR-199a/214簇的活性来促进HIPS-NSCs的肿瘤趋向性,miR-199a/214簇参与了低氧刺激的细胞迁移的调节。我们首先开发了一种杆状病毒传递的CRISPR干扰系统(CRISPRi),它通过RNA引导的催化死亡Cas9(DCas9)立体地阻断miR-199a/214簇启动子中的E-box元件。然后,我们将该CRISPRi系统应用于HIPS-NSCs,并成功地抑制了microRNA基因簇中miR-199a-5p、miR-199a-3p和miR-214的表达。同时,HIF1a、MET、MAPK1等与低氧刺激细胞迁移调控相关的靶基因表达水平上调。进一步的迁移分析表明,靶向抑制miR-199a/214簇显著增强了HIPS-NSCs在体内外的肿瘤趋向性。这些发现表明CRISPRi在基于NSC的肿瘤靶向基因治疗中有一种新的应用。
The human induced pluripotent stem cell (hiPSC) provides a breakthrough approach that helps overcoming ethical and allergenic challenges posed in application of neural stem cells (NSCs) in targeted cancer gene therapy. However, the tumor-tropic capacity of hiPSC-derived NSCs (hiPS-NSCs) still has much room to improve. Here we attempted to promote the tumor tropism of hiPS-NSCs by manipulating the activity of endogenous miR-199a/214 cluster that is involved in regulation of hypoxia-stimulated cell migration. We first developed a baculovirus-delivered CRISPR interference (CRISPRi) system that sterically blocked the E-box element in the promoter of the miR-199a/214 cluster with an RNA-guided catalytically dead Cas9 (dCas9). We then applied this CRISPRi system to hiPS-NSCs and successfully suppressed the expression of miR-199a-5p, miR-199a-3p, and miR-214 in the microRNA gene cluster. Meanwhile, the expression levels of their targets related to regulation of hypoxia-stimulated cell migration, such as HIF1A, MET, and MAPK1, were upregulated. Further migration assays demonstrated that the targeted inhibition of the miR-199a/214 cluster significantly enhanced the tumor tropism of hiPS-NSCs both in vitro and in vivo. These findings suggest a novel application of CRISPRi in NSC-based tumor-targeted gene therapy.
DOI: 10.1038/cddis.2012.134
发表时间: 2012-10-04
影响因子: 9
作者:
通讯作者: --
特纳综合征患者特异性诱导多能干细胞中整个 X 染色体的单亲二体性
DOI: 10.1038/celldisc.2015.22
发表时间: 2015
期刊: Cell discovery
影响因子: 33.5
作者:
Luo Y;Zhu D;Du R;Gong Y;Xie C;Xu X;Fan Y;Yu B;Sun X;Chen Y
通讯作者: Chen Y
DOI: 10.1038/srep22312
发表时间: 2016-02-29
期刊: Scientific reports
影响因子: 4.6
作者:
Chang H;Yi B;Ma R;Zhang X;Zhao H;Xi Y
通讯作者: Xi Y
DOI: 10.1093/nar/gku1198
发表时间: 2015-02-18
影响因子: 14.9
作者:
Ho TT;Zhou N;Huang J;Koirala P;Xu M;Fung R;Wu F;Mo YY
通讯作者: Mo YY
DOI: 10.1038/mtm.2015.50
发表时间: 2016
期刊: Molecular therapy. Methods & clinical development
影响因子: --
作者:
Kwang TW;Zeng X;Wang S
通讯作者: Wang S